The Effects of Antimicrobial Resistance and the Compatibility of Initial Antibiotic Treatment on Clinical Outcomes in Patients With Diabetic Foot Infection

We aimed to determine pathogen microorganisms, their antimicrobial resistance patterns, and the effect of initial treatment on clinical outcomes in patients with diabetic foot infection (DFI). Patients with DFI from 5 centers were included in this multicenter observational prospective study between June 2018 and June 2019. Multivariate analysis was performed for the predictors of reinfection/death and major amputation. A total of 284 patients were recorded. Of whom, 193 (68%) were male and the median age was 59.9 ± 11.3 years. One hundred nineteen (41.9%) patients had amputations, as the minor (n = 83, 29.2%) or major (n = 36, 12.7%). The mortality rate was 1.7% with 4 deaths. A total of 247 microorganisms were isolated from 200 patients. The most common microorganisms were Staphylococcus aureus (n = 36, 14.6%) and Escherichia coli (n = 32, 13.0%). Methicillin resistance rates were 19.4% and 69.6% in S aureus and coagulase-negative Staphylococcus spp., respectively. Multidrug-resistant Pseudomonas aeruginosa was detected in 4 of 22 (18.2%) isolates. Extended-spectrum beta-lactamase-producing Gram-negative bacteria were detected in 20 (38.5%) isolates of E coli (14 of 32) and Klebsiella spp. (6 of 20). When the initial treatment was inappropriate, Klebsiella spp. related reinfection within 1 to 3 months was observed more frequently. Polymicrobial infection (p = .043) and vancomycin treatment (p = .007) were independent predictors of reinfection/death. Multivariate analysis revealed vascular insufficiency (p = .004), hospital readmission (p = .009), C-reactive protein > 130 mg/dL (p = .007), and receiving carbapenems (p = .005) as independent predictors of major amputation. Our results justify the importance of using appropriate narrow-spectrum empirical antimicrobials because higher rates of reinfection and major amputation were found even in the use of broad-spectrum antimicrobials.

[1]  K. Kaye,et al.  The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections , 2020, Open forum infectious diseases.

[2]  J. V. van Netten,et al.  Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update) , 2020, Diabetes/metabolism research and reviews.

[3]  R. Forsythe,et al.  Definitions and criteria for diabetic foot disease , 2020, Diabetes/metabolism research and reviews.

[4]  R. Kirsner,et al.  Diagnosis and Management of Diabetic Foot Infections , 2020 .

[5]  T. Demirdal,et al.  Meta‐analysis of risk factors for amputation in diabetic foot infections , 2019, Diabetes/metabolism research and reviews.

[6]  Ignatius Ezeani,et al.  Predictors of lower extremity amputation in patients with diabetic foot ulcer: findings from MEDFUN, a multi-center observational study , 2019, Journal of Foot and Ankle Research.

[7]  Margarida Pinto,et al.  Diabetic Foot Infection: Causative Pathogens and Empiric Antibiotherapy Considerations—The Experience of a Tertiary Center , 2019, The international journal of lower extremity wounds.

[8]  Benjamin A Lipsky,et al.  Remission in diabetic foot infections: Duration of antibiotic therapy and other possible associated factors , 2018, Diabetes, obesity & metabolism.

[9]  F. Yılmaz,et al.  Influence of multidrug resistant organisms on the outcome of diabetic foot infection. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[10]  D. Armstrong,et al.  Microbiology and Antimicrobial Therapy for Diabetic Foot Infections , 2018, Infection & chemotherapy.

[11]  Benjamin A Lipsky,et al.  Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection? , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[12]  S. Bhadada,et al.  The microbiology of diabetic foot infections in patients recently treated with antibiotic therapy: A prospective study from India. , 2017, Journal of diabetes and its complications.

[13]  É. Senneville,et al.  Optimising the quality and outcomes of treatments for diabetic foot infections , 2016, Expert review of anti-infective therapy.

[14]  Benjamin A Lipsky.  Diabetic foot infections: Current treatment and delaying the ‘post‐antibiotic era’ , 2016, Diabetes/metabolism research and reviews.

[15]  Benjamin A Lipsky,et al.  Diabetic foot infections: what have we learned in the last 30 years? , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[16]  F. Yılmaz,et al.  Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  Xiaoqun He,et al.  Reliability and Validity of the Perfusion, Extent, Depth, Infection and Sensation (PEDIS) Classification System and Score in Patients with Diabetic Foot Ulcer , 2015, PloS one.

[18]  D. Armstrong,et al.  Microbiology of diabetic foot infections: from Louis Pasteur to ‘crime scene investigation’ , 2015, BMC Medicine.

[19]  Benjamin A Lipsky,et al.  Do Diabetic Foot Infections With Methicillin-Resistant Staphylococcus aureus Differ From Those With Other Pathogens? , 2014, The international journal of lower extremity wounds.

[20]  David G Armstrong,et al.  2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. , 2013, Journal of the American Podiatric Medical Association.

[21]  G. Simon,et al.  Diabetic foot infections: the role of microbiology and antibiotic treatment. , 2012, Seminars in vascular surgery.

[22]  J. Lavigne,et al.  Diabetes and foot infection: more than double trouble , 2012, Diabetes/metabolism research and reviews.

[23]  W. Jeffcoate,et al.  A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot , 2012, Diabetes/metabolism research and reviews.

[24]  A. Boulton,et al.  Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections , 2010, Drugs.

[25]  J. J. Cabrera-Galván,et al.  Are diabetic foot ulcers complicated by MRSA osteomyelitis associated with worse prognosis? Outcomes of a surgical series , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[26]  V. Jarlier,et al.  Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact , 2004, Diabetic medicine : a journal of the British Diabetic Association.